RxDoctor Payments DataLook up a doctor →

Sonu Bhatia, MD

Internal Medicine · Henderson, NVNPI 1245281120

Payments from drug & device makers

$17,832in general payments, 2019–2025

Across 1,052 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • GSK$1K
  • Pfizer$1K
  • Boehringer Ingelheim$1K
  • Novo Nordisk$975
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$17,786100%
  • Education$460%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)160$2,237
AstraZeneca46$1,966
GSK75$1,140
Pfizer86$1,117
Boehringer Ingelheim70$1,093
Novo Nordisk55$975
Amgen(2 entities)53$886
Lilly USA, LLC83$833
Abbott32$714
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC45$538
Otsuka America Pharmaceutical, Inc.17$527
Astellas Pharma US Inc23$496
Novartis26$407
Johnson & Johnson(3 entities)23$359
Amarin Pharma, Inc.19$303
Sanofi-aventis U.S. LLC19$277
Esperion Therapeutics, Inc.15$256
Lundbeck LLC15$254
Gilead12$241
Merck14$228
Biohaven Pharmaceutical Holding Company Ltd.11$206
Biohaven Pharmaceuticals, Inc.10$188
Takeda Pharmaceuticals U.S.A., Inc.11$168
QOL Medical, LLC8$149
IBSA Pharma Inc.8$148
Almatica Pharma LLC7$116
Ironwood Pharmaceuticals, Inc7$110
Nestle Healthcare Nutrition Inc.6$103
Eisai Inc.6$100
Exact Sciences6$97
Bayer6$97
Vertiflex, Inc.1$89
Antares Pharma, Inc.6$88
Mylan Specialty L.p.3$76
Medtronic1$73
Genentech USA, Inc.4$66
Axsome Therapeutics, Inc.3$62
Phathom Pharmaceuticals, Inc.3$60
Dexcom, Inc.4$60
Lucid Diagnostics Inc.1$60
Kowa Pharmaceuticals America, Inc.3$58
Teva Pharmaceuticals USA, Inc.4$54
Jazz Pharmaceuticals Inc.3$53
Shire North American Group Inc3$48
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$47
Aimmune Therapeutics, Inc.2$39
Kaleo, Inc.2$39
Sunovion Pharmaceuticals Inc.3$39
Vanda Pharmaceuticals Inc.1$37
Shield Therapeutics Inc2$35
Radius Health, Inc.2$33
Idorsia Pharmaceuticals US Inc2$32
Ironshore Pharmaceuticals Inc.2$29
Mannkind Corporation2$27
Acerus Pharmaceuticals Corporation1$25
Sun Pharmaceutical Industries Inc.1$23
Verona Pharma, Inc.1$20
Cranial Technologies, Inc1$20
Regeneron Healthcare Solutions, Inc.1$19
Promius Pharma LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,832 in reported general payments places this provider in the 95th percentile of 1,071 internal medicine providers in Nevada.

See all internal medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$482,267
Medicare patients
865
Services billed
7,672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide124$159,527
OzempicSemaglutide127$151,983
EliquisApixaban107$142,489
FarxigaDapagliflozin Propanediol94$101,221
JardianceEmpagliflozin99$98,892
XareltoRivaroxaban42$43,464
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$35,639
JanuviaSitagliptin Phosphate26$30,669
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog34$28,628
Repatha SureclickEvolocumab32$27,081
TradjentaLinagliptin20$26,306
LinzessLinaclotide24$22,834
RybelsusSemaglutide11$20,690
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$19,909
ViberziEluxadoline11$17,132

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$975$172,673138 claims
Lilly USA, LLCMounjaro$833$159,527124 claims
PfizerEliquis, Paxlovid$1,117$145,331138 claims
Boehringer IngelheimJardiance, Tradjenta$1,093$125,198119 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,966$109,199107 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$1,140$50,67079 claims
AbbVieLinzess, Viberzi, Synthroid$2,237$44,554114 claims
Johnson & JohnsonXarelto$359$43,46442 claims
MerckJanuvia, Belsomra$228$35,76938 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,071 internal medicine providers in Nevada.

Other internal medicine in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →